Management of Neuropsychiatric Symptoms in Neurocognitive Disorders.

Focus (Am Psychiatr Publ)

Dr. Legesse is with the Division of Geriatric Psychiatry, and Dr. Forester is with the Division of Geriatric Psychiatry and the Geriatric Mood Disorders Research Program, McLean Hospital, Belmont, Massachusetts (e-mail: Dr. Babadi is with the Swartz Program in Theoretical Neuroscience, Center for Brain Science, Harvard University, Cambridge, Massachusetts.

Published: January 2017

Dementias, renamed neurocognitive disorders (NCDs) in the , are defined by acquired decline in cognitive and functional abilities. now also includes mild NCD, which incorporates the previous diagnosis of mild cognitive impairment. recognizes the following etiologies for NCDs: NCD due to Alzheimer's disease, vascular NCD, NCD with Lewy bodies, frontotemporal NCD, substance-/medication-induced NCD, NCD due to traumatic brain injury, NCD due to Huntington's disease, NCD due to HIV infection, NCD due to prion disease, and NCD due to other medical conditions. In this review, the authors discuss a wide variety of interventions that have been studied for the treatment and management of neuropsychiatric symptoms of patients with NCDs. In addition to nonpharmacological interventions, several classes of medications-including antipsychotics, antidepressants, anticonvulsants, and cholinesterase inhibitors-have been studied for this indication.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6519624PMC
http://dx.doi.org/10.1176/appi.focus.20160031DOI Listing

Publication Analysis

Top Keywords

ncd
11
management neuropsychiatric
8
neuropsychiatric symptoms
8
neurocognitive disorders
8
ncd ncd
8
disease ncd
8
symptoms neurocognitive
4
disorders dementias
4
dementias renamed
4
renamed neurocognitive
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!